Trial Profile
Clinical Trials Insight: 700020876
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Ragweed allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Hypersensitivity
- Focus Registrational; Therapeutic Use
- Sponsors Curalogic
- 13 Feb 2007 New trial record.